TWOPTICS SYSTEMS DESIGN SL

Their core work

Twoptics Systems Design is a Madrid-based optical engineering SME that designs and integrates optical hardware with computational image processing algorithms. Their core capability is combining custom optics with software-driven analysis — as demonstrated by their coordination of OCCIM-DEV, a project targeting optimised computational imaging for transparent micro-devices. They also apply optical expertise to biomedical contexts, having participated in OPTOGENERAPY, a research initiative exploring light-activated protein therapy for multiple sclerosis. In practice, they occupy the engineering bridge between precision optical design and digital imaging pipelines, serving both industrial inspection and scientific instrumentation needs.

What they specialise in

How they've shifted over time

Both of Twoptics' H2020 projects launched in 2017, which makes it impossible to track any meaningful shift in focus within the programme. Their two simultaneous project tracks — computational imaging for micro-devices and optogenetic medical therapy — suggest they were already operating across industrial and biomedical optical domains at the same time rather than evolving from one to the other. No keyword metadata is available for either project, so any finer-grained evolution analysis would be speculation.

With only two projects, both beginning in 2017 and no later EU activity on record, no reliable trend can be identified — a consortium builder should treat Twoptics as a focused optical engineering SME whose post-2020 direction is not visible in EU project data.

How they like to work

Twoptics splits evenly between leading projects and joining as a partner: they coordinated the focused OCCIM-DEV coordination action (EUR 61,250) while participating as a consortium member in the larger OPTOGENERAPY research project. Their 11 distinct partners across 7 countries, accumulated over just two projects, suggests they engage in diverse, multi-country consortia rather than relying on a fixed circle of collaborators. As a small SME, they most likely enter consortia to provide a specific optical or imaging capability that academic and larger industrial partners lack in-house.

Twoptics has worked with 11 distinct partners across 7 countries through only two projects — a relatively broad geographic spread for a company of this size. No repeated partnership patterns can be identified from two projects alone, but the spread suggests they are comfortable operating in pan-European consortia.

What sets them apart

Twoptics occupies an unusual niche: a small optical systems design firm that bridges precision computational imaging and biomedical light-based technologies. Most imaging SMEs remain in industrial inspection or security; Twoptics' involvement in optogenetic therapy research signals broader scientific reach across domains. For a consortium that needs an optical engineering partner who understands both machine vision and photobiology instrumentation, they are a rare combination.

Highlights from their portfolio

• OCCIM-DEV
  Twoptics served as coordinator, confirming their capacity to lead EU projects in their core domain of combined computational imaging and image processing for transparent micro-devices.
• OPTOGENERAPY
  Their largest funded project (EUR 246,410) and the one that extends their optical expertise furthest — into light-activated protein therapy for multiple sclerosis, a significant interdisciplinary stretch.